Although in the past 20 years, great progress has been made in understanding the pathogenesis of AD and great efforts have been made in developing drug therapy, current treatments, such as N-methyl d-aspartate receptor antagonist and acetylcholinesterase inhibitors, fail to exert satisfactory curative effect [32]. The gene discussed is ACHE; the disease is Alzheimer disease.